Attached files
| file | filename |
|---|---|
| S-1/A - Cellectar Biosciences, Inc. | v171998_s1a.htm |
| EX-10.47 - Cellectar Biosciences, Inc. | v171998_ex10-47.htm |
| EX-10.46 - Cellectar Biosciences, Inc. | v171998_ex10-46.htm |
Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the
Board of Directors
Novelos
Therapeutics, Inc.
We
consent to the use of our report dated March 17, 2009, relating to the financial
statements of Novelos Therapeutics, Inc. as of December 31, 2008 and 2007 and
for the years then ended in the Registration Statement on Form S-1 of Novelos
Therapeutics, Inc., relating to the registration of 19,000,000 shares of common
stock. We also consent to the use of our name and the reference to us in the
‘‘Experts’’ section of this registration statement.
/s/ Stowe
& Degon LLC
Westborough,
Massachusetts
January
26, 2010